Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Patritumab Biosimilar – Anti-ERBB3 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG1, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Patritumab Biosimilar - Anti-ERBB3 mAb - Research Grade |
|---|---|
| Source | CAS 1262787-83-6 |
| Species | Homo sapiens |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Patritumab,AMG888,U3-1287,ERBB3,anti-ERBB3 |
| Reference | PX-TA1284 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
Description of Patritumab Biosimilar - Anti-ERBB3 mAb - Research Grade
General information on Anti-ERBB3[Homo sapiens] (Patritumab) Monoclonal Antibody
Patritumab has been investigated for the treatment of Lung Cancer, Solid Tumors, Neoplasms by Site, Head and Neck Neoplasms.
Related products
Antigen
Receptor tyrosine-protein kinase erbB-3(ERBB3)Fc Tag
PX-P4725 210€Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.